Skip to main content
Top
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Research article

Dietary profile of patients with Stargardt’s disease and Retinitis Pigmentosa: is there a role for a nutritional approach?

Authors: Francesco Sofi, Andrea Sodi, Fabrizio Franco, Vittoria Murro, Dania Biagini, Alba Miele, Giacomo Abbruzzese, Dario Pasquale Mucciolo, Gianni Virgili, Ugo Menchini, Alessandro Casini, Stanislao Rizzo

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

Stargardt’s disease (STGD) and Retinitis Pigmentosa (RP) are inherited retinal degenerations that may be affected, in opposite way, by diet.

Methods

Dietary profile was assessed in 24 patients with STGD and in 56 patients with RP. We documented in only 6 out of 24 (25 %) STGD patients a daily intake of vitamin A within the recommended range while 14/24 (58.3 %) reported a high daily intake and 4/24 (16.7 %) showed a low daily intake. With regard to RP, 4/56 (7.1 %) reported to be within the recommended range, 37/56 (66.1 %) reported high daily intake and 15/56 (26.8 %) showed low daily intake of vitamin A.

Results

Interestingly, STGD patients with low vitamin A intake (<600 µg RAE/day) showed significantly better visual acuity with respect to those introducing higher intake of vitamin A.

Conclusion

The present study suggests insuitable nutrient intakes among patients with STGD and RP, especially for daily intake of vitamin A. The results may be used to provide tailored nutritional interventions in these patients.
Literature
1.
go back to reference Lien EI, Hammond BR. Nutritional influences on visual development and function. Progr Ret Eye Res. 2011;30:188–203.CrossRef Lien EI, Hammond BR. Nutritional influences on visual development and function. Progr Ret Eye Res. 2011;30:188–203.CrossRef
3.
go back to reference Chappelow AV, Traboulsi EI. Stargardt Disease. In: Traboulsi EI, editor. Genetic Diseases of the Eye. Oxford-New York: Oxford University Press; 2012. p. 467–75.CrossRef Chappelow AV, Traboulsi EI. Stargardt Disease. In: Traboulsi EI, editor. Genetic Diseases of the Eye. Oxford-New York: Oxford University Press; 2012. p. 467–75.CrossRef
5.
go back to reference Ferreyra HA, Heckenlively JR. Retinitis Pigmentosa. In: Traboulsi EI, editor. Genetic Diseases of the Eye. Oxford-New York: Oxford University Press; 2012. p. 381–92.CrossRef Ferreyra HA, Heckenlively JR. Retinitis Pigmentosa. In: Traboulsi EI, editor. Genetic Diseases of the Eye. Oxford-New York: Oxford University Press; 2012. p. 381–92.CrossRef
6.
go back to reference Radu RA, Yuan Q, Hu J, Peng JH, Lloyd M, Nusinowitz S, et al. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci. 2008;49:3821–9.CrossRefPubMedPubMedCentral Radu RA, Yuan Q, Hu J, Peng JH, Lloyd M, Nusinowitz S, et al. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci. 2008;49:3821–9.CrossRefPubMedPubMedCentral
7.
go back to reference Aleman TS, Cideciyan AV, Windsor EA, Schwartz SB, Swider M, Chico JD, et al. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations. Invest Ophthalmol Vis Sci. 2007;48:1319–29.CrossRefPubMedPubMedCentral Aleman TS, Cideciyan AV, Windsor EA, Schwartz SB, Swider M, Chico JD, et al. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations. Invest Ophthalmol Vis Sci. 2007;48:1319–29.CrossRefPubMedPubMedCentral
8.
go back to reference Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761–72.CrossRefPubMed Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761–72.CrossRefPubMed
9.
go back to reference Berson EL, Rosner B, Sandberg MA, Moser A, Brockhurst RJ, Hayes KC, et al. Clinical trial of docosohexanoic acid in patients with Retinitis Pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297–305.CrossRefPubMed Berson EL, Rosner B, Sandberg MA, Moser A, Brockhurst RJ, Hayes KC, et al. Clinical trial of docosohexanoic acid in patients with Retinitis Pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297–305.CrossRefPubMed
10.
go back to reference Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Further evaluation of docosohexanoic acid in patients with Retinitis Pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1306–14.CrossRefPubMed Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Further evaluation of docosohexanoic acid in patients with Retinitis Pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1306–14.CrossRefPubMed
11.
go back to reference Berson EL, Rosner B, Sandberg MA, Weigel-Di Franco C, Willett W. ω-3 intake and visual acuity in patients with Retinitis Pigmentosa receiving vitamin A. Arch Ophthalmol. 2012;130:707–11.CrossRefPubMedPubMedCentral Berson EL, Rosner B, Sandberg MA, Weigel-Di Franco C, Willett W. ω-3 intake and visual acuity in patients with Retinitis Pigmentosa receiving vitamin A. Arch Ophthalmol. 2012;130:707–11.CrossRefPubMedPubMedCentral
12.
go back to reference Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, et al. Clinical trial of lutein in patients with Retinitis Pigmentosa receiving vitamin A. Arch Ophthalmol. 2010;128:403–11.CrossRefPubMedPubMedCentral Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, et al. Clinical trial of lutein in patients with Retinitis Pigmentosa receiving vitamin A. Arch Ophthalmol. 2010;128:403–11.CrossRefPubMedPubMedCentral
13.
go back to reference Koenekoop RK. The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review. Ophthalmic Genet. 2003;24:75–80.CrossRefPubMed Koenekoop RK. The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review. Ophthalmic Genet. 2003;24:75–80.CrossRefPubMed
14.
go back to reference Passerini I, Sodi A, Giambene B, Mariottini A, Menchini U, Torricelli F. Novel mutations of the ABCR gene in Italian patients with Stargardt Disease. Eye. 2010;24:158–64.CrossRefPubMed Passerini I, Sodi A, Giambene B, Mariottini A, Menchini U, Torricelli F. Novel mutations of the ABCR gene in Italian patients with Stargardt Disease. Eye. 2010;24:158–64.CrossRefPubMed
17.
go back to reference Radu RA, Han Y, Bui TV, Nusinowitz S, Bok D, Lichter J, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci. 2005;46:4393–401.CrossRefPubMed Radu RA, Han Y, Bui TV, Nusinowitz S, Bok D, Lichter J, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci. 2005;46:4393–401.CrossRefPubMed
18.
go back to reference Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of Retinitis Pigmentosa? Arch Ophthalmol. 2010;128:493–5.CrossRefPubMed Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of Retinitis Pigmentosa? Arch Ophthalmol. 2010;128:493–5.CrossRefPubMed
Metadata
Title
Dietary profile of patients with Stargardt’s disease and Retinitis Pigmentosa: is there a role for a nutritional approach?
Authors
Francesco Sofi
Andrea Sodi
Fabrizio Franco
Vittoria Murro
Dania Biagini
Alba Miele
Giacomo Abbruzzese
Dario Pasquale Mucciolo
Gianni Virgili
Ugo Menchini
Alessandro Casini
Stanislao Rizzo
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0187-3

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue